Epidural analgesia for parturients with type 1 von Willebrand disease

International Journal of Obstetric Anesthesia

Volumn 16, Issue 3, 2007, Pages 231-235

  Marrache, D ^a   Mercier, F J ^a   Boyer Neumann, C ^a   Roger Christoph, S ^a   Benhamou, D ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Epidural analgesia; Labor; PFA 100 closure times; Pregnancy; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; EPIDURAL ANESTHESIA; FEMALE; HEMOSTASIS; HUMAN; TERTIARY HEALTH CARE; VON WILLEBRAND DISEASE;

ADENOSINE DIPHOSPHATE; ADULT; ANALGESIA, EPIDURAL; ANALGESIA, OBSTETRICAL; BLEEDING TIME; EPINEPHRINE; FACTOR VIII; FEMALE; HEMOSTASIS; HUMANS; INFANT, NEWBORN; PREGNANCY; RETROSPECTIVE STUDIES; VASOCONSTRICTOR AGENTS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 34249994909     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2007.02.013     Document Type: Article

References (21)

1. Mannucci P.M. Treatment of von Willebrand's Disease. N Engl J Med 351 (2004) 683-694
2. Federici A.B., Castaman G., Mannucci P.M., and Italian Association of Hemophilia Centers (AICE). Guidelines for the diagnosis and the management of von Willebrand disease in Italy. Haemophilia 8 (2002) 607-621
3. Budde U., Drewke E., Mainusch K., and Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 28 (2002) 173-190
4. Chediak J.R., Alban G.M., and Maxey B. Von Willebrand's disease and pregnancy: Management during delivery and outcome of offspring. Am J Obstet Gynecol 155 (1986) 618-624
5. Kadir R.A., Lee C.A., Sabin C.A., Pollard D., and Economides D.L. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 105 (1998) 314-321
6. Cohen S., Daitch J.S., Amar D., and Goldiner P.L. Epidural analgesia for labor and delivery in a patient with von Willebrand's disease. Reg Anesth 14 (1989) 95-97
7. Milaskiewicz R.M., Holdcroft A., and Letsky E. Epidural anaesthesia and Von Willebrand's disease. Anaesthesia 45 (1990) 462-464
8. Suddeth B.H., Schmalenberger K.P., Mandell G.L., and Golebiewsky K.A. Von Willebrand's disease and regional anesthesia in the parturient. Anesthesiology 98 Supp 1 (2003) A57
9. Fressinaud E., Veyradier A., Sigaud M., Boyer-Neumann C., Le Boterff C., and Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol 106 (1999) 777-783
10. Fressinaud E., Veyradier A., Truchaud F., et al. Screening for von Willebrand disease with a new analyser using high shear stress: A study of 60 cases. Blood 91 (1998) 1325-1331
11. Dimitriadou C., Sultan Y., Levy-Toledano S., Bernal-Hoyos J.E., and Caen J. Quantitative study of bleeding time and platelet function during thrombopenic purpura. Nouv Presse Med 3 (1974) 1425-1428
12. Miller C.H., Haff E., Platt S.J., et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 1 (2003) 2191-2197
13. Sadler J.E. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2 (2004) 1720-1723
14. ®) in patients with a bleeding tendency. Swiss Med Wkly 132 (2002) 443-448
15. Ortel T.L., James A.H., Thames E.H., Moore K.D., and Greenberg C.S. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. Thromb Haemost 84 (2000) 93-97
16. Vincelot A., Nathan N., Collet D., Mehaddi Y., Granchamp P., and Julia A. Platelet function during pregnancy: an evaluation using the PFA-100 analyser. Br J Anaesth 87 (2001) 890-893
17. Mammen E.F., Comp P.C., Gosselin R., et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24 (1998) 195-202
18. Cattaneo M., Federici A.B., Lecchi A., et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 82 (1999) 35-39
19. Cammerer U., Dietrich W., Rampf T., Braun S.L., and Richter J.A. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96 (2003) 51-57
20. Fattorutto M., Pradier O., Schmartz D., Ickx B., and Barvais L. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass?. Br J Anaesth 90 (2003) 692-693
21. Quiroga T., Goycoolea M., Munoz B., et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2 (2004) 890-891